Allmed Solutions Ltd
TASE:ALMD
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
30
46.4
|
Price Target |
|
We'll email you a reminder when the closing price reaches ILS.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Gross Margin
Allmed Solutions Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | IL |
Market Cap | 36m ILS |
Gross Margin | N/A |
Country | JP |
Market Cap | 6.8T JPY |
Gross Margin |
86%
|
Country | CH |
Market Cap | 37.9B CHF |
Gross Margin |
55%
|
Country | DK |
Market Cap | 200.9B DKK |
Gross Margin |
68%
|
Country | US |
Market Cap | 16.9B USD |
Gross Margin |
70%
|
Country | KR |
Market Cap | 9.9T KRW |
Gross Margin |
15%
|
Country | CA |
Market Cap | 6.9B USD |
Gross Margin |
61%
|
Country | CN |
Market Cap | 48.6B CNY |
Gross Margin |
73%
|
Country | US |
Market Cap | 6.3B USD |
Gross Margin |
65%
|
Country | US |
Market Cap | 6.1B USD |
Gross Margin |
47%
|
Country | UK |
Market Cap | 4.8B GBP |
Gross Margin |
56%
|
Allmed Solutions Ltd
Glance View
Allmed Solutions Ltd. engages in the development, manufacture, and marketing of minimally invasive products internationally in various medical disciplines. Its products are used by physicians to treat a number of diseases and patients worldwide. The firm's product lines include: Covered Stents, which offers Ureteral Stent (URS), Round Posterior Stent (RPS), Triangular Prostatic Stent (TPS), Bulbar Stent (BUS) and Biliary Stent (BIS); Uro-Gynecology, which offers EndoFast Reliant System, EndoFast Resorb, EndoFast Reliant MN and EndoFast Reliant SCP; Type II Diabetes, which offers the Gastro-duodenal sleeve (GDS), as well as Cardiovascular, which offers WIRION EPD System. The firm's products serve patients with the following medical conditions: Pelvic Organ Prolapse (POP), Sacrocolpopexy, Male Stress Urinary Incontinence (SUI), Urethral/Ureteral Stricture, Carotid Stenosis, Biliary Stricture and Type II Diabetes.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Allmed Solutions Ltd's most recent financial statements, the company has Gross Margin of 0%.